Matches in SemOpenAlex for { <https://semopenalex.org/work/W4353005087> ?p ?o ?g. }
- W4353005087 endingPage "144" @default.
- W4353005087 startingPage "111" @default.
- W4353005087 abstract "Renin-angiotensin system (RAS) plays an indispensable role in regulating blood pressure through its effects on fluid and electrolyte balance. As an aside, cumulative evidence from experimental to clinical studies supports the notion that dysregulation of RAS contributes to the pro-inflammatory, pro-oxidative, and pro-fibrotic processes that occur in pulmonary diseases like asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and acute lung injury (ALI). Pharmacological intervention of the various RAS components can be a novel therapeutic strategy for the treatment of these respiratory diseases. In this chapter, we first give a recent update on the RAS, and then compile, review, and analyse recent reports on targeting RAS components as treatments for respiratory diseases. Inhibition of the pro-inflammatory renin, angiotensin-converting enzyme (ACE), angiotensin (Ang) II, and Ang II type 1 receptor (AT1R) axis, and activation of the protective ACE2, AT2R, Ang (1-7), and Mas receptor axis have demonstrated varying degrees of efficacies in experimental respiratory disease models or in human trials. The newly identified alamandine/Mas-related G-protein-coupled receptor member D pathway has shown some therapeutic promise as well. However, our understanding of the RAS ligand-and-receptor interactions is still inconclusive, and the modes of action and signaling cascade mediating the newly identified RAS receptors remain to be better characterized. Clinical data are obviously lacking behind the promising pre-clinical findings of certain well-established molecules targeting at different pathways of the RAS in respiratory diseases. Translational human studies should be the focus for RAS drug development in lung diseases in the next decade." @default.
- W4353005087 created "2023-03-23" @default.
- W4353005087 creator A5021243725 @default.
- W4353005087 creator A5030850198 @default.
- W4353005087 creator A5047094196 @default.
- W4353005087 creator A5054751264 @default.
- W4353005087 creator A5090299043 @default.
- W4353005087 creator A5090456197 @default.
- W4353005087 date "2023-01-01" @default.
- W4353005087 modified "2023-09-24" @default.
- W4353005087 title "Targeting the renin angiotensin system for respiratory diseases" @default.
- W4353005087 cites W1493720279 @default.
- W4353005087 cites W1538839647 @default.
- W4353005087 cites W1550074279 @default.
- W4353005087 cites W1874170221 @default.
- W4353005087 cites W1969664428 @default.
- W4353005087 cites W1976883767 @default.
- W4353005087 cites W1994038070 @default.
- W4353005087 cites W2002071018 @default.
- W4353005087 cites W2006789008 @default.
- W4353005087 cites W2014231321 @default.
- W4353005087 cites W2015945747 @default.
- W4353005087 cites W2021341590 @default.
- W4353005087 cites W2023080320 @default.
- W4353005087 cites W2023670145 @default.
- W4353005087 cites W2040235874 @default.
- W4353005087 cites W2048878186 @default.
- W4353005087 cites W2052182309 @default.
- W4353005087 cites W2066073474 @default.
- W4353005087 cites W2070459088 @default.
- W4353005087 cites W2077646921 @default.
- W4353005087 cites W2092088523 @default.
- W4353005087 cites W2104718344 @default.
- W4353005087 cites W2115006322 @default.
- W4353005087 cites W2116077776 @default.
- W4353005087 cites W2117081272 @default.
- W4353005087 cites W2117662118 @default.
- W4353005087 cites W2119643490 @default.
- W4353005087 cites W2121831767 @default.
- W4353005087 cites W2124011595 @default.
- W4353005087 cites W2154283964 @default.
- W4353005087 cites W2164119092 @default.
- W4353005087 cites W2279350596 @default.
- W4353005087 cites W2342512713 @default.
- W4353005087 cites W2410545784 @default.
- W4353005087 cites W249128934 @default.
- W4353005087 cites W2558125867 @default.
- W4353005087 cites W2616042947 @default.
- W4353005087 cites W2624024060 @default.
- W4353005087 cites W2749302177 @default.
- W4353005087 cites W2751073142 @default.
- W4353005087 cites W2754957776 @default.
- W4353005087 cites W2756541052 @default.
- W4353005087 cites W2758621237 @default.
- W4353005087 cites W2791708939 @default.
- W4353005087 cites W2793712559 @default.
- W4353005087 cites W2794956042 @default.
- W4353005087 cites W2797560926 @default.
- W4353005087 cites W2805771055 @default.
- W4353005087 cites W2900167300 @default.
- W4353005087 cites W2917103516 @default.
- W4353005087 cites W2931208839 @default.
- W4353005087 cites W2932722755 @default.
- W4353005087 cites W2944333166 @default.
- W4353005087 cites W2945427193 @default.
- W4353005087 cites W2950993137 @default.
- W4353005087 cites W2951703270 @default.
- W4353005087 cites W2954170665 @default.
- W4353005087 cites W2954603315 @default.
- W4353005087 cites W2969292601 @default.
- W4353005087 cites W2980912116 @default.
- W4353005087 cites W2988032890 @default.
- W4353005087 cites W2989687853 @default.
- W4353005087 cites W2992024634 @default.
- W4353005087 cites W2998922965 @default.
- W4353005087 cites W3011376519 @default.
- W4353005087 cites W3016748094 @default.
- W4353005087 cites W3018448193 @default.
- W4353005087 cites W3023462248 @default.
- W4353005087 cites W3047108186 @default.
- W4353005087 cites W3048313828 @default.
- W4353005087 cites W3080378920 @default.
- W4353005087 cites W3081562004 @default.
- W4353005087 cites W3082571004 @default.
- W4353005087 cites W3088272386 @default.
- W4353005087 cites W3089450771 @default.
- W4353005087 cites W3095110182 @default.
- W4353005087 cites W3121491857 @default.
- W4353005087 cites W3126194737 @default.
- W4353005087 cites W3130438253 @default.
- W4353005087 cites W3131713170 @default.
- W4353005087 cites W3134770078 @default.
- W4353005087 cites W3137575537 @default.
- W4353005087 cites W3162827342 @default.
- W4353005087 cites W3173822292 @default.
- W4353005087 cites W3178389255 @default.
- W4353005087 cites W3179911610 @default.
- W4353005087 cites W3189650315 @default.